Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Stillwaggon E, Carrier CS, Sautter M, McLeod R.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1333. doi: 10.1371/journal.pntd.0001333.

2.

Cost-benefit analysis of screening for toxoplasmosis during pregnancy.

Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammälä P, Teramo K, Koskela P.

Scand J Infect Dis. 1995;27(3):265-72.

PMID:
8539552
3.

Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.

Logar J, Petrovec M, Novak-Antolic Z, Premru-Srsen T, Cizman M, Arnez M, Kraut A.

Scand J Infect Dis. 2002;34(3):201-4.

PMID:
12030394
4.

[Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].

Binquet C, Wallon M, Quantin C, Gadreau M, Peyron F.

Rev Epidemiol Sante Publique. 2002 Oct;50(5):475-87. Review. French.

PMID:
12471340
5.

Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria.

Aspöck H, Pollak A.

Scand J Infect Dis Suppl. 1992;84:32-7.

PMID:
1290071
6.

Economic evaluation of preventive programmes against congenital toxoplasmosis.

Stray-Pedersen B, Jenum P.

Scand J Infect Dis Suppl. 1992;84:86-96. Review.

PMID:
1290083
7.

Screening programme for congenital toxoplasmosis in France.

Thulliez P.

Scand J Infect Dis Suppl. 1992;84:43-5.

PMID:
1290073
8.

Prenatal screening for toxoplasmosis.

Bader TJ, Macones GA, Asch DA.

Obstet Gynecol. 1997 Sep;90(3):457-64.

PMID:
9277662
9.

[How can the cost of screening for toxoplasmosis during pregnancy be reduced?].

Ancelle T, Yera H, Talabani H, Lebuisson A, Thulliez P, Dupouy-Camet J.

Rev Epidemiol Sante Publique. 2009 Dec;57(6):411-7. doi: 10.1016/j.respe.2009.08.011. French.

PMID:
19932576
10.

Congenital toxoplasmosis: is screening desirable?

Foulon W.

Scand J Infect Dis Suppl. 1992;84:11-7. Review.

PMID:
1290068
11.

Toxoplasmosis in pregnancy: prevention, screening, and treatment.

Paquet C, Yudin MH; Society of Obstetricians and Gynaecologists of Canada..

J Obstet Gynaecol Can. 2013 Jan;35(1):78-81. English, French.

PMID:
23343802
12.

Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?

Eskild A, Oxman A, Magnus P, Bjørndal A, Bakketeig LS.

J Med Screen. 1996;3(4):188-94. Review.

PMID:
9041483
13.

Serological screening for toxoplasmosis in pregnancy in Slovenia.

Logar J, Novak-Antolic Z, Zore A.

Scand J Infect Dis. 1995;27(2):163-4.

PMID:
7660082
14.

[Toxoplasmosis diagnosis in pregnancy: computer assisted follow-up interpretation of serologic tests].

Nagy S, Hayde M, Panzenböck B, Adlassnig KP, Pollak A.

Wien Klin Wochenschr. 1997 Sep 5;109(16):641-6. German.

PMID:
9412085
15.

Systematic serologic screening for toxoplasmosis in pregnancy.

Thorp JM Jr.

Obstet Gynecol. 1993 Jul;82(1):162-3. No abstract available.

PMID:
8369057
16.

[Cost-benefit analysis of screening for congenital toxoplasmosis].

Sagmeister M, Gessner U, Kind C, Horisberger B.

Schweiz Med Wochenschr Suppl. 1995;65:103S-112S. Review. German.

PMID:
7716447
17.

The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.

Koskiniemi M, Lappalainen M, Koskela P, Hedman K, Ammälä P, Hiilesmaa V, Teramo K.

Scand J Infect Dis Suppl. 1992;84:70-4.

PMID:
1290079
19.

Supplemental Content

Support Center